Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Second primary malignancies after tandem autoSCT in patients with multiple myeloma

Samer Al Hadidi, MD, University of Arkansas for Medical Sciences, Little Rock, AR, discusses the results of a study evaluating the occurrence of second primary malignancies in patients with multiple myeloma treated with tandem autologous stem cell transplantation (autoSCT). This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.